Yanda International Hospital
Bookimed ne rajoute pas de frais pour les traitements de Maladie rénale chronique. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Maladie rénale chronique et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Maladie rénale chronique.
Professor Fan Yu is Chief Physician and Director of Kidney Transplantation. His center ranked first in Fujian for three straight years in liver and kidney transplants. His team performed 112 kidney transplants and one combined liver-kidney transplant over two years.
He specializes in kidney transplantation, post-transplant complications, and immunosuppressive management. He developed a system to improve long-term graft and patient survival.
He pioneered the diagnosis and treatment of chronic and subclinical rejection. He has led more than 10 grants as principal investigator and published over 30 SCI-indexed papers. He is Vice Chairman of the Transplant Surgeon Branch of the Chinese Medical Doctor Association and the Organ Transplant Branch of the Shanghai Medical Association. He is Editor-in-Chief of Chinese Kidney Friends and serves on the editorial boards of over 20 journals, including the Chinese edition of Transplantation.
Chinese hospitals treat chronic kidney disease (CKD) using integrative protocols that combine traditional Chinese medicine (TCM) with Western nephrology. This multi-targeted approach focuses on reducing proteinuria, managing edema, and delaying dialysis through herbal decoctions, acupuncture, and circulation-improving therapies within JCI-accredited facilities.
Bookimed Expert Insight: Yanda International Hospital maintains Class A level III status, the highest ranking in China, by integrating international protocols with TCM for over 2,500,000 patients annually. While Western medicine manages blood pressure, hospitals like Yanda use TCM as a secondary layer to improve life quality. Patients should prioritize doctors like Dr. Fan Yu at Xiamen Humanity Hospital, who balances traditional support with over 30 years of advanced kidney transplantation expertise.
Patient Consensus: Patients note that TCM works best as supportive care for fatigue and swelling rather than a standalone cure. Many emphasize checking for nephrotoxic herbs to ensure treatments do not stress the kidneys further.
Chinese kidney disease treatments involve risks of herbal toxicity and nephrotoxicity from compounds like aristolochic acid. These toxins can cause irreversible organ scarring or interstitial nephritis. Advanced centers like Yanda International Hospital address these risks by combining international protocols with monitored traditional approaches.
Bookimed Expert Insight: Patients seeking integrated care should prioritize Class A Level III clinics like Yanda International Hospital. These facilities hold Joint Commission International (JCI) accreditation and serve over 2,500,000 patients yearly. This high volume and strict certification ensure that traditional methods are supervised by specialists who use international safety standards to prevent toxic interactions.
Patient Consensus: Patients warn that feeling better initially can mask worsening lab results. They emphasize the need to monitor creatinine and eGFR immediately when starting any new herbal formula.
Combining Chinese herbal therapies with SGLT2 or ACE inhibitors is risky and requires expert medical supervision. These combinations may cause life-threatening drug-herb interactions, dangerous potassium spikes, or acute kidney injury. Patients must never mix these treatments without a nephrologist reviewing every herbal ingredient for potential toxicity.
Bookimed Expert Insight: While general advice warns against all herbs, data from top Chinese institutions like Yanda International Hospital show a different pattern. They utilize a Class A Level III framework to integrate international protocols with traditional medicine safely. This structured environment uses JCI-accredited safety standards to monitor drug-herb interactions in real-time. Choosing a hospital with these specific credentials ensures that herbal integrations are based on standardized, non-toxic formulas rather than unverified supplements.
Patient Consensus: Patients emphasize that herbal teas are not inherently gentle for compromised kidneys. They warn against any products with hidden ingredients and prioritize frequent blood tests to track creatinine and potassium spikes.
Top-tier Chinese hospitals for Chronic Kidney Disease include JCI-accredited facilities like Yanda International Hospital and specialized centers like Xiamen Humanity Hospital. These institutions offer advanced hemodialysis, traditional Chinese medicine integration, and complex kidney transplantation. Leading academic centers in Beijing and Shanghai provide multidisciplinary care for end-stage renal disease.
Bookimed Expert Insight: While many search for boutique clinics, the strongest outcomes for complex cases are found in high-volume hospitals. Xiamen Humanity Hospital completed 112 kidney transplants in two years. This volume ensures surgical teams maintain sharp skills for managing long-term graft survival and rejection. Such specialized experience is critical for international patients seeking more than just routine dialysis.
Patient Consensus: Patients note that while international wings offer better English support, seeking out large academic centers is vital for advanced kidney care. Experience with vascular access and 24-hour emergency monitoring is a top priority for those traveling for long-term treatment.
China provides unique access to advanced small-molecule therapies for chronic kidney disease. These include first-in-class oral inhibitors like Roxadustat and Desidustat. Chinese regulators often approve these medications ahead of Western authorities. Facilities utilize integrated protocols combining Western medicine with researched molecular compounds.
Bookimed Expert Insight: Advanced nephrology care in China is heavily concentrated in Class A level III institutions like Yanda International Hospital. These centers handle massive patient volumes, reaching 2,500,000 yearly. This high volume allows surgeons like Dr. Fan Yu to develop specialized protocols for subclinical transplant rejection. Patients can access experimental Western-style drug therapies years before they reach other global markets.
Patient Consensus: Patients note that leading Chinese centers use advanced dialysis modes like HDF more aggressively than many Western settings. They emphasize having all pathology records ready, as major clinics escalate treatment rapidly if kidneys show instability.
Dialysis survival in major Chinese cities aligns with international standards, reporting a 95.4% 1-year survival rate for urban patients. High-resource facilities in Beijing and Shanghai maintain a 5-year survival rate of approximately 74.1%. Top-tier hospitals prioritize vascular access safety and strict infection control for international patients.
Bookimed Expert Insight: Quality varies significantly by hospital type rather than city geography alone. Yanda International Hospital in Beijing holds JCI accreditation and Class A level III status. This represents China's highest clinical tier for safety. While many urban centers use twice-weekly protocols, these elite facilities can accommodate Western thrice-weekly standards. Confirming this prescription early is vital for maintaining your established care continuity.
Patient Consensus: Patients note that administrative ease and English-speaking staff matter more than city-wide data. Many emphasize securing stable schedules and verifying insurance billing before arrival to avoid care interruptions.
Foreign patients are ineligible for deceased-donor kidney transplants in mainland China. National regulations prioritize Chinese citizens and permanent residents for organ allocation. The only legal pathway for international patients is through a living-related donor of the same nationality who travels with them.
Bookimed Expert Insight: While mainland China has high-volume centers like Yanda International Hospital serving 2.5 million patients yearly, transplant surgery is strictly regulated. High-priority surgeons like Dr. Fan Yu at Xiamen Humanity Hospital focus on long-term graft survival. Data shows China ranks lower in international requests for transplants compared to Turkey or India due to these rigid legal requirements for foreign nationals.
Patient Consensus: Patients emphasize that documentation is the biggest hurdle. You must provide complete medical records and clear proof of the donor relationship to pass strict ethical screenings meant to prevent organ trading.